Diffuse alveolar hemorrhage following administration of tirofiban or abciximab: A nemesis of platelet glycoprotein IIb/iIIa inhibitors
We describe three patients who developed severe pulmonary hemorrhage following administration of tirofiban (one patient) and abciximab (two patients). Pulmonary hemorrhage associated with abciximab use has been described, but to the best of our knowledge there has been no previous reports of this co...
Saved in:
Published in | Catheterization and cardiovascular interventions Vol. 49; no. 2; pp. 181 - 184 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
New York
John Wiley & Sons, Inc
01.02.2000
Wiley-Liss |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | We describe three patients who developed severe pulmonary hemorrhage following administration of tirofiban (one patient) and abciximab (two patients). Pulmonary hemorrhage associated with abciximab use has been described, but to the best of our knowledge there has been no previous reports of this complication with tirofiban. Cathet. Cardiovasc. Intervent. 49:181–184, 2000. © 2000 Wiley‐Liss, Inc. |
---|---|
ISSN: | 1522-1946 1522-726X |
DOI: | 10.1002/(SICI)1522-726X(200002)49:2<181::AID-CCD14>3.0.CO;2-J |